Group treatment for self-stigma in people with mental disorders in Northeast Italy
Official title: Assessing the Effectiveness and Feasibility of Group-based Treatment for Self-stigma in People With Mental Disorders: a Pragmatic Multisite Randomized Controlled Trial in Routine Mental Health Services in North-east Italy
Run by Universita di Verona · NCT06567145 · Data updated 2026-11-12
This study is testing a group therapy called Narrative Enhancement and Cognitive Therapy to see if it can help people with mental disorders in Northeast Italy feel better about themselves and reduce feelings of self-stigma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 416 (estimated) |
| Sponsor | Universita di Verona Academic / other |
| Locations | 1 site (Verona) |
| Status | Recruiting |
| Started | October 1, 2024 |
| Main results expected | October 1, 2025 |
| Study ends | October 1, 2025 |
| Registry record updated | November 26, 2024 |
| Trial ID | NCT06567145 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with specific mental health diagnoses who exhibit moderate levels of self-stigma.
✕Probably not a fit
Patients with primary personality disorders or substance dependence, as well as those unable to provide informed consent, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy and feasibility of Narrative Enhancement and Cognitive Therapy (NECT), a group-based intervention designed to reduce self-stigma among individuals with mental disorders. The trial involves 416 patients from 26 mental health centers in Northeast Italy and is structured as a pragmatic, multicenter, randomized controlled trial with two parallel arms. Participants will undergo 20 sessions of NECT, focusing on improving psychological dimensions such as self-esteem, hope, and empowerment while reducing self-stigma. The study aims to address the harmful effects of self-stigma on treatment adherence and quality of life.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the self-esteem and quality of life for patients with mental disorders by reducing self-stigma.
How similar studies have gone: Previous studies have shown promising results in reducing self-stigma through similar therapeutic approaches, indicating potential for success in this trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants must be 18 years or older. 2. Individuals must have a diagnosis of schizophrenia, schizoaffective disorder, schizoid disorder, schizophreniform disorder, bipolar I or II disorder, or major depressive disorder, according to DSM-5 criteria. 3. Participants must be outpatients with clinical stability for at least 3 months, with no changes in pharmacological treatment during this period. 4. Participants must have sufficient knowledge of written and spoken Italian. 5. Participants must score above 1 on the ISMI (Internalized Stigma of Mental Illness) scale, indicating at least moderate levels of self-stigma. Exclusion Criteria: 1. Individuals unable to provide informed consent are excluded. 2. Participants with intellectual disabilities are excluded. 3. Individuals with primary diagnosis of personality disorder or substance dependence condition are excluded. 4. Participants engaged in other programs that could influence self-stigma (e.g., social cognitive rehabilitation, social skills training) during the study are excluded.
Where it's running
-
Azienda Ospedaliera Universitaria Integrata (AOUI) Verona
Verona, Italy Recruiting
Study contacts
- Study coordinator: Antonio Lasalvia, MD, PhD
- Email: antonio.lasalvia@univr.it
- Phone: 045 828 3901
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stigma Healing Inventory: See if a global program can reduce stigma for kids with cancer and their caregivers
This study tests a stigma-reduction program for children with cancer and their caregivers to see if it lowers stigma across different cultures.
-
Trauma-focused group therapy for adults with trauma symptoms in primary care
A group-based trauma therapy delivered in primary care to see if it helps adults with trauma-related symptoms more than usual care.
-
Honest, Open, Proud for justice-involved veterans
This trial tests a peer-delivered stigma-reduction program for veterans with co-occurring mental health or substance use disorders who are involved with the justice system, to see if different delivery intensities help more veterans engage in care.
-
Care Disengagement Prevention for People Living with HIV in Indonesia
This intervention tests a stigma-reduction approach to help people living with HIV in Indonesia stay connected with HIV care.
-
Does extra family income improve child mental health and brain biology in low-income families?
This study tests whether three years of extra income for parents can improve their child’s mental health and neuroimmune function.
-
Understanding and Targeting Self-Regulatory Control in Bulimia Nervosa
In women with bulimia nervosa, this study tests whether real-time brain feedback during eating, paired with a 4-week text-message program, can help improve self-control and reduce symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.